show
urin
sampl
result
obtain
cbb
method
agre
obtain
mtp
bc
btc
pyr
method
comparison
studi
show
bc
correl
better
mtp
method
btc
cbb
method
urin
csf
sampl
base
slope
intercept
correl
r
valu
bc
wide
use
disinfect
much
less
expens
reagent
especi
dye
cbb
pyr
also
inhibit
bacteri
contamin
reason
better
reagent
stabil
shephard
white
compar
four
protein
precipitantsbc
btc
trichloroacet
acid
sulfosalicyl
acid
nephelometryand
found
bc
good
precis
agre
close
trichloroacet
acidponceau
dyebind
method
hand
nephelometr
method
shephard
white
linear
mgl
protein
similar
measur
rang
mgl
report
author
imprecis
studi
precis
linear
method
better
nephelometr
method
nephelomet
also
expens
use
mani
smalland
mediums
clinic
laboratori
conclus
present
new
turbidimetr
method
correl
better
mtp
method
btc
cbb
method
precis
mtp
cbb
pyr
btc
method
better
precis
recoveri
critic
decis
concentr
rang
satisfactori
albuminglobulin
respons
analyt
rang
use
less
expens
access
chemic
suitabl
autom
poon
kc
allen
chan
pakcheung
ng
rossa
wk
chiu
iren
l
ang
yukwan
tong
ender
ko
ng
franki
wt
cheng
albert
li
elli
kl
hon
taifai
fok
ym
denni
lo
centr
emerg
infecti
diseas
depart
clinic
oncolog
chemic
patholog
paediatr
chines
univers
hong
kong
princ
wale
hospit
shatin
new
territori
hong
kong
sar
address
correspond
author
depart
clinic
oncolog
chines
univers
hong
kong
princ
wale
hospit
ngan
shing
st
shatin
new
territori
hong
kong
special
administr
region
china
email
tcwpoon
cuhkeduhk
outbreak
sever
acut
respiratori
syndrom
sar
affect
countri
five
contin
suspect
probabl
case
death
sar
epidem
infect
case
report
hong
kong
diseas
infecti
particularli
within
healthcar
set
earli
diagnosi
essenti
control
spread
sar
identifi
isol
infect
patient
diagnost
test
develop
detect
either
antibodi
revers
transcriptionpcr
rtpcr
product
sar
coronaviru
sarscov
sarscov
antibodi
reliabl
detect
around
day
diseas
onset
quantit
realtim
rtpcr
assay
hand
allow
detect
sarscov
within
first
week
ill
recent
studi
show
detect
sensit
could
approach
plasma
serum
sampl
sar
patient
asid
improv
analyt
clinic
sensit
rtpcr
assay
also
possibl
develop
new
type
assay
basi
biolog
variabl
andor
technolog
past
year
surfaceenhanc
laser
desorptionion
timeofflight
mass
spectrometri
selditof
ms
appli
discoveri
diagnost
proteom
signatur
cancer
prostat
cancer
ovarian
cancer
breast
cancer
hepatocellular
carcinoma
report
presenc
plasma
proteom
signatur
serial
blood
sampl
eight
pediatr
patient
sar
correl
sarscov
rna
concentr
plasma
serial
plasma
sampl
investig
studi
examin
sarscov
rna
realtim
rtpcr
recent
report
studi
pediatr
patient
admit
new
territori
east
cluster
hospit
author
hospit
hong
kong
satisfi
surveil
case
definit
sar
patient
recruit
march
may
inform
consent
obtain
patient
parent
ethic
approv
obtain
institut
review
board
serial
blood
sampl
use
studi
collect
patient
sampl
collect
routin
blood
test
includ
monitor
lymphocyt
count
biochem
indic
enzym
convalesc
sera
patient
test
igg
antibodi
sarscov
sarscovinfect
cell
indirect
immunofluoresc
assay
patient
serolog
posit
sarscov
igg
antibodi
neg
control
blood
sampl
pediatr
patient
suffer
fever
infect
sar
collect
plasma
sarscov
rna
concentr
pediatr
patient
compar
result
adult
sar
patient
report
previous
seven
eight
studi
patient
close
contact
infect
adult
wherea
one
patient
sar
contact
histori
patient
fever
mean
durat
fever
day
rang
day
cours
hospit
patient
initi
treat
oral
ribavirin
mgkg
daili
continu
mean
durat
day
rang
day
seven
treat
oral
prednisolon
start
mean
day
rang
day
onset
fever
durat
prednisolon
treatment
day
plasma
sampl
subject
seldi
proteinchip
analysi
similar
method
describ
previous
denatur
protein
l
plasma
sampl
ad
l
solut
moll
urea
gl
chap
mmoll
trishcl
ph
dilut
l
bind
buffer
mmoll
sodium
acet
mll
triton
ph
give
final
dilut
proteinchip
array
preequilibr
twice
l
bind
buffer
min
l
dilut
sampl
appli
proteinchip
array
duplic
incub
shake
room
temperatur
min
incub
array
wash
five
time
bind
buffer
rins
twice
deioniz
water
airdri
sinapin
acid
matrix
mll
acetonitril
contain
mll
trifluoroacet
acid
ad
array
proteinchip
array
read
proteinchip
pb
ii
reader
proteinchip
biomark
system
ciphergen
biosystem
measur
mass
intens
protein
peak
common
peak
among
seldi
mass
spectra
identifi
quantifi
biomark
wizard
softwar
ciphergen
biosystem
data
mine
peak
intens
normal
total
peak
intens
follow
log
transform
avoid
identif
proteom
featur
might
associ
investig
sar
patient
sar
diseas
sarsspecif
proteom
featur
defin
seldi
proteom
featur
fulfil
three
criteria
normal
peak
intens
increas
sar
patient
onset
fever
b
normal
peak
intens
decreas
time
recoveri
c
normal
peak
intens
posit
correl
concentr
sarscov
plasma
compar
normal
proteom
data
earliest
avail
plasma
sampl
collect
pediatr
sar
patient
within
first
week
day
day
control
plasma
sampl
pediatr
patient
influenza
fever
use
twoclass
unpair
test
median
fals
discoveri
rate
zero
signific
analysi
microarray
algorithm
stanford
univers
identifi
proteom
featur
posit
associ
sar
among
proteom
featur
normal
peak
intens
proteom
featur
significantli
decreas
recoveri
wilcoxon
signedrank
test
p
spearman
rank
correl
test
use
analyz
correl
proteom
featur
sarscov
rna
serial
plasma
sampl
eight
pediatr
sar
patient
fifteen
posit
correl
plasma
sarscov
rna
concentr
p
valu
see
tabl
data
supplement
accompani
onlin
version
technic
brief
http
wwwclinchemorgcont
fig
illustr
similar
chang
plasma
concentr
sarscov
rna
peak
intens
three
repres
sarsspecif
proteom
featur
treatment
period
potenti
use
sarsspecif
proteom
featur
detect
pediatr
sar
patient
within
first
week
admiss
evalu
roc
curv
analysi
differenti
sar
sampl
collect
within
first
week
collect
day
admiss
control
sampl
roc
curv
area
sarsspecif
proteom
featur
p
valu
see
tabl
onlin
data
supplement
result
suggest
identifi
sarsspecif
proteom
featur
potenti
marker
detect
sar
clinic
chemistri
recent
reliabl
studi
use
selditof
ms
technolog
question
suggest
find
may
bias
artifact
relat
natur
clinic
sampl
use
experiment
detail
sampl
storag
condit
mass
spectrometr
instrument
andor
bioinformat
analysi
believ
problem
overcom
use
good
experiment
design
stringent
criteria
defin
proteom
featur
diseas
specif
signific
proteom
featur
could
valid
multipl
level
studi
illustr
success
stringent
system
approach
analyz
seldi
proteom
data
identif
sarsspecif
proteom
featur
better
fulfil
differ
datafilt
criteria
becom
less
like
identifi
proteom
featur
identifi
chanc
identifi
featur
result
bia
patient
select
studi
although
filter
criteria
set
identif
sarsspecif
proteom
featur
signific
proteom
featur
identifi
later
roc
curv
analys
show
sarsspecif
proteom
featur
potenti
biomark
detect
sar
character
circul
sarsspecif
proteom
featur
may
help
us
understand
diseas
patholog
patient
respons
suggest
selditof
ms
technolog
prefer
toward
detect
highabund
protein
molecul
acutephas
reaction
protein
haptoglobin
isoform
serum
amyloid
identifi
technolog
cancerassoci
proteom
featur
possibl
sarsspecif
proteom
featur
identifi
studi
also
acutephas
protein
exampl
sarsspecif
proteom
featur
mz
may
haptoglobin
kda
serum
amyloid
isoform
proteom
featur
mz
may
transferrin
kda
clusterin
kda
proteom
featur
mz
may
doubli
charg
h
fibrinogen
kda
recent
chines
studi
shown
serum
concentr
acutephas
protein
complement
creactiv
protein
significantli
higher
patient
sar
patient
pneumonia
healthi
individu
cat
felin
coronaviru
infect
also
led
increas
concentr
haptoglobin
serum
amyloid
acid
glycoprotein
igg
igm
conclus
studi
demonstr
presenc
uniqu
proteom
signatur
sera
sar
patient
increas
within
first
week
infect
decreas
recoveri
posit
correl
sarscov
viral
load
similar
studi
adult
sampl
undertaken
determin
whether
similar
chang
plasmaserum
proteom
pattern
seldi
tofm
perform
micropl
format
highthroughput
technolog
may
possibl
develop
quick
seldi
proteinchip
assay
detect
monitor
potenti
sar
patient
